Aureus Asset Management LLC boosted its position in Danaher Co. (NYSE:DHR – Get Rating) by 1.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,160 shares of the conglomerate’s stock after buying an additional 170 shares during the quarter. Aureus Asset Management LLC’s holdings in Danaher were worth $2,697,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Freedom Wealth Alliance LLC acquired a new position in Danaher in the 4th quarter valued at $27,000. My Personal CFO LLC acquired a new stake in Danaher in the 4th quarter worth $29,000. Private Ocean LLC grew its position in Danaher by 1,485.7% in the 4th quarter. Private Ocean LLC now owns 111 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 104 shares during the last quarter. Bellwether Advisors LLC grew its position in Danaher by 157.7% in the 3rd quarter. Bellwether Advisors LLC now owns 134 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 82 shares during the last quarter. Finally, WFA of San Diego LLC acquired a new stake in Danaher in the 4th quarter worth $36,000. 77.26% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Danaher news, SVP Daniel Raskas sold 19,847 shares of the business’s stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $228.50, for a total value of $4,535,039.50. Following the completion of the transaction, the senior vice president now directly owns 38,673 shares of the company’s stock, valued at $8,836,780.50. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, SVP Daniel Raskas sold 19,847 shares of Danaher stock in a transaction that occurred on Wednesday, May 31st. The shares were sold at an average price of $228.50, for a total transaction of $4,535,039.50. Following the completion of the sale, the senior vice president now owns 38,673 shares in the company, valued at approximately $8,836,780.50. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Joakim Weidemanis sold 9,934 shares of Danaher stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $245.27, for a total transaction of $2,436,512.18. Following the sale, the executive vice president now owns 91,423 shares of the company’s stock, valued at approximately $22,423,319.21. The disclosure for this sale can be found here. Over the last three months, insiders sold 34,466 shares of company stock valued at $8,103,781. Insiders own 11.10% of the company’s stock.
Danaher Trading Up 1.4 %
Danaher (NYSE:DHR – Get Rating) last announced its earnings results on Tuesday, April 25th. The conglomerate reported $2.36 earnings per share for the quarter, topping analysts’ consensus estimates of $2.26 by $0.10. Danaher had a net margin of 22.40% and a return on equity of 16.70%. The company had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.06 billion. During the same period in the previous year, the firm posted $2.76 earnings per share. The company’s revenue was down 6.8% on a year-over-year basis. Research analysts forecast that Danaher Co. will post 9.43 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Shareholders of record on Friday, June 30th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date is Thursday, June 29th. Danaher’s dividend payout ratio is presently 11.64%.
Analyst Ratings Changes
Several analysts have issued reports on DHR shares. William Blair restated an “outperform” rating on shares of Danaher in a research report on Wednesday, April 26th. Citigroup decreased their price target on shares of Danaher from $325.00 to $300.00 in a research report on Wednesday, April 26th. SVB Leerink restated an “outperform” rating on shares of Danaher in a research report on Monday, May 1st. Robert W. Baird reduced their price objective on shares of Danaher from $309.00 to $275.00 in a report on Wednesday, April 26th. Finally, StockNews.com initiated coverage on shares of Danaher in a report on Thursday, May 18th. They set a “buy” rating for the company. Three research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $294.06.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.
Read More
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- As Peloton Shares Fall Over 90%, A Comeback Strategy Surges
- Inflation, The Fed, And The Summer Rally
- How to Trade Stocks Online the Right Way
- SentinelOne Stock is Down, But Is it Out?
- Oracle Has Spoken: The AI Cloud Is Bigger And Growing Faster
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Get Rating).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
